3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Breast
1
Conditions
Wounds and Injuries
1
Non-Melanoma Skin Cancers
1
Keratosis, Actinic
1
Head and Neck Neoplasms
1
Cancer Pain
1
Breast Neoplasms
1
Interventions
Cisplatin
28
Radiotherapy
20
pembrolizumab
9
Paclitaxel
9
Surveys and Questionnaires
8
Cetuximab
8
Fluorouracil
7
Docetaxel
7
Radiotherapy, Intensity-Modulated
6
Carboplatin
6
apatinib
5
Low-Level Light Therapy
5
Blood Specimen Collection
5
durvalumab
4
Standard of Care
4
Magnetic Resonance Imaging
4
Gemcitabine
4
Cyclophosphamide
4
Celecoxib
4
Tegafur
3
Radiation
3
Oncolytic Virotherapy
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Lidocaine
3
Immunoenzyme Techniques
3
Drug Therapy
3
Chemotherapy, Adjuvant
3
Biopsy
3
toripalimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Head and Neck Neoplasms
×
Gels
×
Clear all
NCT05800834
2023-09-28
MorphineGEL
Instituto Nacional de Cancer, Brazil
Phase 2
Unknown
106 enrolled